VIEWS DECISIONS 1 (S-XI) TO 6 (S-XI) OF THE UNITED NATIONS DRUG COMMISSION, WHICH WERE ADOPTED AT 1035. SESSION HELD IN VIENNA ON 29 JANUARY 1990 AND COMMUNICATED BY THE SECRETARY-GENERAL OF THE UNITED NATIONS ON 5 MARCH 1990, ON THE BASIS OF THE REPORTS AND RECOMMENDATIONS RECEIVED FROM THE WORLD HEALTH ORGANISATION TO INDUCE THE SUBSEQUENT SUBSTANCES LISTED IN THE LISTS ANNEXED TO THE 1961 SINGLE CONVENTION ON NARCOTIC DRUGS, NUMBER 264 OF 4 NOVEMBER 1981;

TAKING INTO ACCOUNT THE PROVISIONS OF PARAGRAPHS 3 (III) AND 5 OF ARTICLE 3. OF THE SAID SINGLE CONVENTION, AND BY VIRTUE OF THE POWERS CONFERRED ON ARTICLE 2 OF CHAPTER I OF LAW 17/1967 OF 9 APRIL ON NARCOTIC DRUGS,

THIS MINISTRY HAS HAD WELL TO DISPOSE:

FIRST. INCLUDE IN LISTS I AND IV ANNEXED TO THE 1961 SINGLE CONVENTION ON NARCOTIC DRUGS THE FOLLOWING SUBSTANCES:

ALPHA-METHYLTHIOPHENTANIL, OF FORMULA N (1 (1-METHYL-2) ETIL) 4 PIPERIDIL) PROPIONANILIDE.

FOR-FLUOFENTANIL, OF FORMULA 4 ' -FLUORO-N (1-FENETIL -4-PIPERIDIL) PROPIONANILIDE.

BETA-HYDROXYFENTANYL, OF FORMULA N (1 (BETA-HYDROXYPHENETHYL) 4 PIPERIDIL) PROPIONANILIDE.

BETA-HYDROXY-3-METHYLFENTANYL, OF FORMULA N (1 (BETA-HYDROXYPHENETHYL) -3-METHYL-4-PIPERIDYL) PROPIONANILIDE.

THIOPHENTANIL, OF FORMULA N (1-(2 (2-THIENYL) ETHYL) -4PIPERIDYL) PROPIONANILIDE.

3-METHYLTHIOPHENTANIL, OF FORMULA N-(3-METHYL-1-(2 (2-THENYL) ETIL) -4-PIPERIDIL) PROPIONANILIDE.

SECOND. THE SIX ABOVE SUBSTANCES, AS WELL AS THE SALTS, ESTERS AND ETHERS WHICH FORM THEIR FORMATION, MAY NOT BE THE SUBJECT OF PRODUCTION, MANUFACTURE, EXPORT AND IMPORT, TRADE, POSSESSION OR USE, WITH THE EXCEPTION OF QUANTITIES NECESSARY FOR MEDICAL AND SCIENTIFIC RESEARCH, INCLUDING CLINICAL EXPERIMENTS WITH SUCH DRUGS TO BE CARRIED OUT UNDER THE SUPERVISION AND SUPERVISION OF THE GENERAL DIRECTORATE OF PHARMACY AND MEDICAL DEVICES.

THIRD. THE ENTITIES WHICH HOLD OR ARE IMPORTERS OR MANUFACTURERS OF THE SUBSTANCES ABOVE THE ENTRY INTO FORCE OF THIS ORDER SHALL PROCEED TO DECLARE AND DELIVER THEM TO THE GENERAL DIRECTORATE OF PHARMACY AND MEDICAL DEVICES.

FOURTH. THIS ORDER WILL TAKE EFFECT THE DAY AFTER YOUR PUBLICATION IN THE .

MADRID, OCTOBER 19, 1990.

GARCIA VARGAS

ILMO. MR. DIRECTOR GENERAL OF PHARMACY AND MEDICAL DEVICES.